The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo

Haasbach, Emanuel; Muller, Christin; Ehrhardt, Christina; Schreiber, Andre; Pleschka, Stephan; Ludwig, Stephan; Planz, Oliver

dc.contributor.author	Haasbach, Emanuel
dc.contributor.author	Planz, Oliver
dc.date.accessioned	2017-12-08T10:09:08Z
dc.date.available	2017-12-08T10:09:08Z
dc.date.issued	2017
dc.identifier.issn	1872-9096
dc.identifier.uri	http://hdl.handle.net/10900/79154
dc.language.iso	en	en
dc.publisher	Elsevier Science Bv	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.antiviral.2017.03.024
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_00667
utue.publikation.seiten	178-184	de_DE
utue.personen.roh	Haasbach, Emanuel
utue.personen.roh	Muller, Christin
utue.personen.roh	Ehrhardt, Christina
utue.personen.roh	Schreiber, Andre
utue.personen.roh	Pleschka, Stephan
utue.personen.roh	Ludwig, Stephan
utue.personen.roh	Planz, Oliver
dcterms.isPartOf.ZSTitelID	Antiviral Research	de_DE
dcterms.isPartOf.ZS-Volume	142	de_DE
utue.fakultaet	04 Medizinische Fakultät